blog

New eBook: Why and How Emerging Biopharmaceutical Companies Can Do More with Less

By Aaron Fleishman on Tue, Jan 15, 2019 | 1 min read

Ensuring Successful Enrollment of Your Clinical Trials

The market has never been more competitive for small- and mid-size biopharmaceutical companies. While your company may not have the resources or depth of experience as the larger companies, with the right strategies you can find yourself better positioned to deliver results faster and with less expense to reach your clinical trial enrollment goals.

In this free, downloadable ebook, we offer solutions 

Topics: global patient recruitment, Technology, eBook, BBK Worldwide, Patient Recruitment, Patient Retention, Patient Engagement, Trends

The Impact a Travel Program Can Have on Your Patient Recruitment and Engagement Success

By BBK Worldwide on Mon, Jan 7, 2019 | 2 min read

When it comes to the benefits travel programs offer in support of clinical trials, opinions are varied. In a recent article published in International Clinical Trials, BBK’s Hannu Koski and Rob Laurens present compelling data with industry insights. “Talking Travel” looks at the appeal travel assistance programs have from the patients’ perspective.

Topics: patient data, Patient Experience, Patient, BBK Worldwide, Patient Recruitment, Patient Retention, Trends, Patient Travel

100% Talent: Closing the Wage Gap in Boston

By Bonnie A. Brescia on Thu, Mar 31, 2016 | 2 min read

A city where women make on average .83 for every dollar earned by men, Boston is taking steps to close the wage gap through “100% Talent: The Boston Women’s Compact.” The compact is a voluntary pledge that more than 100 Metro Boston-based organizations have already signed, indicating their promise to close the gender wage gap in the workplace. Salary data will be collected and analyzed and companies will have access to research-driven tools and support to address pay gaps and inequities. Proudly, it’s also the first initiative of its kind in the country.

Topics: BBK Worldwide, Wage Gap, Wage Equality

BBK Worldwide Making News at 51st Annual DIA Meeting

By BBK Worldwide on Tue, Jun 16, 2015 | 3 min read

BBK Worldwide makes news at DIA 2015The 51st Annual DIA Meeting kicked off yesterday in Washington, DC. So far it has been a whirlwind of presenting, networking and having fun at our booth (#2026 come see us)! DIA is the perfect time to announce the latest in company news, and we have no shortage of announcements to share this year. 

Topics: BBK Worldwide, mHealth

BBK Worldwide's Guide to Getting the Most out of Your Time at DIA

By BBK Worldwide on Thu, Jun 4, 2015 | 3 min read

Are you planning attend the DIA Annual Meeting later this month in Washington, DC? For those of us working in drug research and development, it’s a great time to connect with the people and organizations working to accelerate the development of new therapies and enhance patient care.

Topics: BBK Worldwide, Conferences

Bonnie A. Brescia to be Featured on Global Reach Broadcast with Té Revesz

By BBK Worldwide on Wed, Oct 8, 2014 | 1 min read

Founded in 1983 with a $30,000 loan and two military surplus desks, BBK Worldwide has become a global, multi-million dollar corporation that is changing the face of patient recruitment for clinical R&D in the pharma and biopharma industries. Today, our founding principals, Bonnie A. Brescia and Joan F. Bachenheimer have created a global enterprise – one that that is true to their philosophies of how a business, its products, services, and culture can create new opportunities for its staff, clients and benefit consumers.

Topics: BBK Worldwide, Webinars

Re-investing in Patient Centricity: A Note from Founding Principal Bonnie A. Brescia

By Bonnie A. Brescia on Fri, Sep 19, 2014 | 2 min read

What would you do if you had access to $3 million dollars to invest in improving the clinical research field? This might be a relatively small budget by some standards, but significant enough to make a difference and BBK has some very specific plans to do just that as we continue to deliver on our value proposition, BBK Worldwide: The Patients To Find the Cure

Topics: BBK Worldwide, Patient Centricity

Three Challenges to Implementing Social Media Into Your Patient Recruitment Campaign

By Aaron Fleishman on Fri, Jul 11, 2014 | 4 min read

Considering a social media campaign for your clinical trial? While there are proven advantages to using social media as a patient recruitment tactic, additional considerations must be explored when deciding if social media fits your campaign’s needs. First, scope out your audience by evaluating the opportunity with a social media listening program. For example, how active and engaged is this study community on social media? Or, how many Facebook groups, outlets, etc. are out there for these patients to find each other? Next, evaluate the outlet – What are all my options when building a social media page? Or, what outlets can I use if I just want to advertise?

Topics: BBK Worldwide, Patient Recruitment, Social Media, Technology

FDA Proposes Social Media Guidelines. Sort of.

By Aaron Fleishman on Thu, Jul 10, 2014 | 3 min read

A few weeks ago, and nearly five years after its open hearing on the topic, the Food and Drug Administration (FDA) finally released its proposed guidelines for how drug and device makers should navigate social media. Much has been written on the new guidelines including a few informative posts by Ed Silverman at the Wall Street Journal. As Silverman notes, among the 50 largest drug makers, half are still not using social media to engage consumers or patients, according to a survey by the IMS Institute for Health Informatics. He also suggests that the FDA will likely use the guidances as trial-and-error blueprints themselves as they run across questions that were not answered or situations that may not have been anticipated.

Topics: BBK Worldwide, Patient Recruitment, Social Media, Technology

Meaningful Data Analysis and Adaptive Patient Recruitment Tactical Efficacy

By Joan F. Bachenheimer on Wed, Jun 25, 2014 | 4 min read

This is the second part of a two-part series by Joan F. Bachenheimer, founding principal, and Matt Kibby, principal, technology and innovation, BBK Worldwide.

Even if you were able to correlate advertising referrals to consented patients with a high degree of accuracy (and then to screen-fail and randomization) the fact of the matter is, "So what?"

Four scenarios spring to mind with regard to the quest for this correlation:

Topics: BBK Worldwide, Patient Recruitment, Technology

 
Subscribe To Our Blog